Stockscreener 앱 받기
6.67
3.57%
0.23
시간 외 거래:
6.52
-0.15
-2.25%
전일 마감가:
$6.44
열려 있는:
$6.5
하루 거래량:
41,149
Relative Volume:
0.16
시가총액:
$3.58M
수익:
-
순이익/손실:
$-8.82M
주가수익비율:
-0.00965
EPS:
-691.4213
순현금흐름:
$-8.08M
1주 성능:
+5.87%
1개월 성능:
+29.26%
6개월 성능:
-95.81%
1년 성능:
-99.73%
1일 변동 폭
$6.15
$6.89
1주일 범위
$6.0301
$7.2887
52주 변동 폭
$4.01
$2,887.50
Endra Life Sciences Inc Stock (NDRA) Company Profile
명칭
Endra Life Sciences Inc
전화
734-335-0468
주소
3600 GREEN COURT, ANN ARBOR, MI
NDRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NDRA
Endra Life Sciences Inc
|
6.67 | 3.58M | 0 | -8.82M | -8.08M | -691.42 |
|
TMO
Thermo Fisher Scientific Inc
|
532.02 | 203.50B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
234.84 | 169.62B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
135.69 | 38.75B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.39 | 35.83B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
415.53 | 34.03B | 3.84B | 866.24M | 792.60M | 10.37 |
Endra Life Sciences Inc 주식(NDRA)의 최신 뉴스
(NDRA) Trading Signals - Stock Traders Daily
Study Highlighting ENDRA Life Sciences TAEUS Technology in Patients with High BMI to be presented at AASLD's The Liver Meeting 2024 - Marketscreener.com
Data I/O And 2 Other Stocks Under $5 Executives Are Buying - MSN
Nexalin Technology (NASDAQ:NXL) and ENDRA Life Sciences (NASDAQ:NDRA) Head-To-Head Survey - Defense World
(NDRA) Technical Data - Stock Traders Daily
ENDRA Life Sciences Inc trading halted, volatility trading pause - TipRanks
ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement - Defense World
ENDRA Life Sciences meets Nasdaq listing standards By Investing.com - Investing.com Australia
ENDRA Life Sciences meets Nasdaq listing standards - Investing.com
Endra Life Sciences regains compliance with Nasdaq - TipRanks
ENDRA Life Sciences Regains Nasdaq Compliance, Clears Path for Strategic Growth | NDRA Stock News - StockTitan
ENDRA Life Sciences Inc. (NDRA) reports earnings - Quartzy
ENDRA Life Sciences Reports Q3 2024 Results and Progress - TipRanks
Post Holdings beats Q4 estimates, issues fiscal 2025 outlook - Investing.com
ENDRA Life Sciences Cuts Operating Costs 52%, Accelerates Clinical Trial Progress | NDRA Stock News - StockTitan
NDRA stock touches 52-week low at $5.23 amid sharp annual decline - Investing.com
500: Something went wrong - Investing.com India
ENDRA's TAEUS Breakthrough: Liver Fat Detection in High-BMI Patients Validated for AASLD 2024 | NDRA Stock News - StockTitan
U.S. Stock market: Wolfspeed, ENDRA Life Sciences, and Clear Secure see significant declines with Wolfspeed down 32.10% - Business Upturn
U.S. Stock market: Cardlytics(- 30%0, CommScope (-26%) and Wolfspeed (-5%) among top losers as the market opens - Business Upturn
Turkey hopes for lower US tariffs under Trump, lira rallies - Investing.com
ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent - The Bakersfield Californian
ENDRA Life Sciences Secures 17th EU Patent for Revolutionary Surgical Technology | NDRA Stock News - StockTitan
ENDRA Life Sciences announces reverse stock split - Investing.com India
ENDRA Life Sciences announces reverse stock split By Investing.com - Investing.com UK
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.14% - MSN
AWH Stock Plummets 6.19% Amid Weak Financial Performance - GuruFocus.com
3 Penny Stocks to Watch Now, 10/24/24 - TipRanks
Stock Market Movers Today • Top Gainers & Losers - Benzinga
Why ENDRA Life Sciences (NDRA) Stock Is Up 140% - Benzinga
ENDRA Life Sciences Activates TAEUS System to Initiate Clinical Study at LMU University Hospital in Germany - The Bakersfield Californian
Market Momentum Report: ENDRA Life Sciences Inc (NDRA)’s Negative Close at 0.21 - The Dwinnex
Examining ENDRA Life Sciences Inc (NDRA) stock is warranted - US Post News
Investor optimism sees biggest jump since June 2020, survey shows By Reuters - Investing.com
ENDRA Life Sciences Inc (NDRA) Stock: A Year of Stock Market Dynamics - The InvestChronicle
The growth track for ENDRA Life Sciences Inc (NDRA) has changed recently - SETE News
ENDRA Life Sciences Inc’s latest rating changes from various analysts - Knox Daily
Should investors be concerned about NDRA’s high price-to-sales ratio? - US Post News
Stock Market Recap: ENDRA Life Sciences Inc (NDRA) Concludes at 0.19, a -4.83 Surge/Decline - The Dwinnex
Digital Realty Trust Inc [DLR] stock was sold by MANDEVILLE JEAN F H P at the price of US$90156.0 - Knox Daily
Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
Adversity is less terrifying than hope: ENDRA Life Sciences Inc (NDRA) - SETE News
ENDRA Life Sciences Inc (NDRA)’s Day in Review: Closing at 0.20, Down by -3.13 - The Dwinnex
ENDRA Life Sciences Inc (NDRA) is a good investment, but the stock may be overvalued - US Post News
A company insider recently sold 139,357 shares of Nuzee Inc [NUZE]. Should You Sale? - Knox Daily
The time has not yet come to remove your chips from the table: ENDRA Life Sciences Inc (NDRA) - SETE News
Benjamin F. Edwards & Company Inc. Purchases 693 Shares of Ingredion Incorporated (NYSE:INGR) - Defense World
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.36% - MSN
Ababaka ku kakiiko k’ebyobulamu barambudde fakitole ekola eddagala - NTV Uganda
ENDRA Life Sciences Inc: Analyzing NDRA Stock Trends - The InvestChronicle
INDIGO Biosciences Launches New Cell-Based Luciferase Reporter Assay for the Human Melanocortin 2 Receptor - EIN News
Endra Life Sciences Inc (NDRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
자본화:
|
볼륨(24시간):